Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ: AUPH · Real-Time Price · USD
15.62
+0.31 (2.02%)
At close: Dec 5, 2025, 4:00 PM EST
15.71
+0.09 (0.58%)
After-hours: Dec 5, 2025, 7:20 PM EST

Aurinia Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
2,0591,2861,2916142,9661,750
Upgrade
Market Cap Growth
79.56%-0.41%110.30%-79.30%69.42%-20.79%
Upgrade
Enterprise Value
1,7861,0251,0472462,6881,367
Upgrade
Last Close Price
15.628.988.994.3222.8713.83
Upgrade
PE Ratio
28.39223.53----
Upgrade
Forward PE
19.2824.06----
Upgrade
PS Ratio
8.055.477.364.5865.0334.93
Upgrade
PB Ratio
5.633.413.421.516.194.29
Upgrade
P/TBV Ratio
5.693.453.461.546.304.39
Upgrade
P/FCF Ratio
17.2129.15----
Upgrade
P/OCF Ratio
17.1528.97----
Upgrade
EV/Sales Ratio
6.724.365.971.8458.9427.27
Upgrade
EV/EBITDA Ratio
17.7632.08----
Upgrade
EV/EBIT Ratio
22.0281.91----
Upgrade
EV/FCF Ratio
14.9323.25----
Upgrade
Debt / Equity Ratio
0.210.210.260.020.020.02
Upgrade
Debt / EBITDA Ratio
0.772.42----
Upgrade
Debt / FCF Ratio
0.651.80----
Upgrade
Asset Turnover
0.490.430.350.260.090.13
Upgrade
Inventory Turnover
1.261.241.982.303.14-
Upgrade
Quick Ratio
5.024.054.868.7611.8412.45
Upgrade
Current Ratio
5.764.575.509.6012.6313.11
Upgrade
Return on Equity (ROE)
20.65%1.52%-19.92%-24.46%-40.81%-29.07%
Upgrade
Return on Assets (ROA)
9.41%1.42%-10.53%-13.74%-22.43%-16.54%
Upgrade
Return on Capital (ROIC)
11.02%1.68%-12.06%-15.46%-24.99%-18.24%
Upgrade
Return on Capital Employed (ROCE)
18.00%2.80%-18.20%-26.20%-36.00%-24.20%
Upgrade
Earnings Yield
3.78%0.45%-6.04%-17.62%-6.10%-5.87%
Upgrade
FCF Yield
5.81%3.43%-2.65%-13.00%-5.33%-4.32%
Upgrade
Buyback Yield / Dilution
1.24%-2.07%-0.93%-9.70%-9.20%-27.36%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.